View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Paycom Software Inc: 1 director

A director at Paycom Software Inc sold 3,900 shares at 141.899USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye

Costs push prices higher

A long list of price increases as costs push prices higher. Q2e EBIT likely down q-o-q: higher maintenance costs. Smart to buy when macro is low.

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye

Q2 preview

Billerud will report its next quarterly results on 19 July. We reiterate BUY with a TP of SEK 110. Q2e EBIT of SEK -65m.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 26, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Require...

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1). As previously disclosed, the ...

 PRESS RELEASE

ExxonMobil and EV battery maker SK On sign MOU regarding U.S. produced...

SPRING, Texas--(BUSINESS WIRE)-- ExxonMobil (NYSE: XOM) has signed a non-binding memorandum of understanding (MOU) with SK On, a global leading electric vehicle (EV) battery developer, that opens the door to secure a multiyear offtake agreement of up to 100,000 metric tons of Mobil™ Lithium from the company’s first planned project in Arkansas. SK On plans to use the lithium in its EV battery manufacturing operations in the U.S. This will contribute to ExxonMobil’s goal, announced in late 2023, of supplying lithium for about one million EV batteries annually by 2030 and support the build out of...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 24, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

ExxonMobil Adds Air Liquide to World’s Largest Low-Carbon Hydrogen Pro...

SPRING, Texas--(BUSINESS WIRE)-- ExxonMobil (NYSE: XOM) and Air Liquide today announced an agreement to support the production of low-carbon hydrogen and low-carbon ammonia at ExxonMobil’s Baytown, Texas facility. The agreement will enable transportation of low-carbon hydrogen through Air Liquide’s existing pipeline network. Additionally, Air Liquide will build and operate four Large Modular Air separation units (LMAs) to supply 9,000 metric tons of oxygen and up to 6,500 metric tons of nitrogen daily to the facility. The LMAs will primarily use low-carbon electricity to reduce the project’s c...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 22, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 21, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 20, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 15, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

OXY OCCIDENTAL PETROLEUM CORPORATION
Z ZILLOW GROUP INC. CLASS C
WSR WHITESTONE REIT
TTSH TILE SHOP HOLDINGS INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
PEB PEBBLEBROOK HOTEL TRUST
PBF PBF ENERGY INC. CLASS A
NFBK NORTHFIELD BANCORP INC.
GLP GLOBAL PARTNERS LP
CTRN CITI TRENDS INC.
BNED BARNES & NOBLE EDUCATION INC.
ACRS ACLARIS THERAPEUTICS INC.
MXCT MAXCYTE INC
HTLD HEARTLAND EXPRESS INC.
NSA NATIONAL STORAGE AFFILIATES TRUST
OPOF OLD POINT FINANCIAL CORP.
ZOM ZOMEDICA PHARMACEUTICALS CORP
HWKN HAWKINS INC.
GBDC GOLUB CAPITAL BDC INC.
UBFO UNITED SECURITY BANCSHARE
AFB ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
BOMN BOSTON OMAHA
ICCH ICC HOLDINGS
CLF CLIFFS NATURAL RESOURCES INC.
FF FIRST MINING GOLD
VPLM VOIP PAL.COM INC.
ANIX ANIXA BIOSCIENCES
RRBI RED RIVER BANCSHARES
MCFT MASTERCRAFT BOAT HOLDINGS
RZLT REZOLUTE
HQL INC.
KRON TEKLA LIFE SCIENCES INVESTORS
TLS KRONOS BIO
CSU TELOS
FTHM CAPITAL SENIOR LIVING
NUVB FATHOM HOLDINGS
CTOS NUVATION BIO INC (A)
TMCI CUSTOM TRUCK ONE SOURCE
FRTX INC.
BHRB TREACE MED CONCEPTS INC
CCFN FRESH TRACKS THERAPEUTICS
VFC INC.
UHG BURKE & HERBERT BANK & TR/VA
BYON CCFNB BANCORP INC
FTREV VF CORPORATION
OPAD UNITED HOMES GROUP INC
STCN BEYON 3D LTD
AEI FORTREA HOLDINGS INC.
GNT OFFERPAD SOLUTIONS INC
CATX STEEL CONNECT INC
PYYX ALSET INC.
PRSO GABELLI NATURAL RESOURCES
GRUSF GOLD AND INCOME TRUST
NUZE PERSPECTIVE THERAPEUTICS
MCI INC.
PYXUS INTERNATIONAL INC
PERASO INC.
GROWN ROGUE INTERNATIONAL INC.
NUZEE INC.
MASSMUTUAL CORPORATE INVESTORS
 PRESS RELEASE

CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare ...

CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars for 2025 payment year FRANKLIN, Tenn., June 14, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyo...

 PRESS RELEASE

Disc Medicine Announces Underwritten Offering of Common Stock

Disc Medicine Announces Underwritten Offering of Common Stock WATERTOWN, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the pricing of an underwritten offering of 4,944,000 shares of its common stock at a price of $36.00 per share. The aggregate gross proceeds to Disc from this offering are expected to be approximately $178.0 million, before deducting underw...

 PRESS RELEASE

Disc Medicine Presents Positive Clinical Data Across Portfolio at the ...

Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress Updated analyses of data from AURORA and BEACON studies further demonstrate clinical activity of bitopertin across multiple measures of erythropoietic protoporphyria (EPP) and support development path forwardAdditional data from the ongoing Phase 1b trial of DISC-0974 in myelofibrosis (MF) patients continued to demonstrate greater than 60% hematologic response rates, with durable increases in hemoglobin levels and reductions in transfusion burdenPositive data from initia...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch